Home
McGuireWoods LLP
Allyson M. Maur
Allyson M. Maur
McGuireWoods LLP
FDA Releases Final Quality Management System Regulation Amendments
19 Feb 2024 | United States
Off-Label "Free Speech" Theory Does Not Fly For Convicted Former Medical Device Executives In 1st Circuit
25 Jan 2024 | United States
FDA Releases Its Scientific Support For Rescheduling Marijuana To Schedule III
24 Jan 2024 | United States
Drug Enforcement Administration Signals Intent To Reschedule Marijuana
15 Jan 2024 | United States
FDA Provides New Resource On Redundancy Risk Management Plans For Critical Food Manufacturers
04 Jan 2024 | United States
FDA Issues Draft Guidance On Providing Health Care Providers With Scientific Information On Unapproved Uses Of Approved/Cleared Medical Products
03 Jan 2024 | United States
FDA Warning Letter Declares Delta-8 And CBD Gummies 'Adulterated Foods'
19 Dec 2023 | United States
Homeland Security And HHS Release Interactive Healthcare Cybersecurity Toolkit
22 Nov 2023 | United States
HHS Rescheduling, SAFER Banking Act May Change The Marijuana Landscape
21 Nov 2023 | United States
FDA Proposes Brominated Vegetable Oil Ban
09 Nov 2023 | United States
FDA Establishes And Solicits Nominations For Digital Health Advisory Committee
08 Nov 2023 | United States
California Bans Four Common Food Additives And 26 Chemicals Used In Cosmetics
19 Oct 2023 | United States
FDA Publishes New Guidance On Cybersecurity In Medical Devices
03 Oct 2023 | United States
Contact Details
New York
New York
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.